Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-07-28Clinical Trial Update: Resistance Training and Sleep in the Elderly [NA]
A study investigated whether resistance training can improve sleep disturbances in elderly participants. The trial status is completed.
-
CLINICAL_TRIALS research · 2011-07-13Clinical Trial Update: Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties [Phase 4]
This Clinical Trial Update reports a Phase 4 study comparing melatonin to methylphenidate for children with ADHD and sleep difficulties; cur…
-
FDA approval · 2011-07-01FDA Approved: ZOLPIDEM TARTRATE — Original Application (Sandoz Inc)
FDA approves Sandoz Inc's original ANDA for zolpidem tartrate, a generic product for the short-term treatment of insomnia.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Non-pharmacological Treatment of Insomnia in Nursing Homes. [NA]
A completed clinical trial update evaluating non-pharmacological treatments for insomnia in nursing home residents, sponsored by University …
-
CLINICAL_TRIALS trial_result · 2011-06-03Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic Impairment [Phase 1]
This is a Phase 1 pharmacokinetic study of LY2624803 in subjects with hepatic impairment evaluating its behavior; the trial in insomnia pati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-05-23FDA Approved: ESZOPICLONE — Original Application (Teva Pharmaceuticals USA, Inc.)
Eszopiclone received FDA approval via its original application for the treatment of insomnia.
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia. [Phase 3]
A Phase 3 trial evaluating whether Rozerem (ramelteon) influences the perception of gastroesophageal reflux symptoms in patients with chroni…
-
FDA approval · 2011-05-09FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for zolpidem tartrate filed by NorthStar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Comparison of IN 10 003 to Placebo in Subjects With Insomnia Suffering From Difficulty in Falling Asleep and Staying Asleep [Phase 2]
Phase 2 study comparing IN 10 003 to placebo in adults with insomnia characterized by difficulty falling asleep and staying asleep has compl…
-
CLINICAL_TRIALS trial_result · 2011-04-07Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Neu-P11 in Subjects With Primary Insomnia [Phase 1]
Phase 1 study assessing safety, tolerability, pharmacokinetics and pharmacodynamics of Neu-P11 in adults with primary insomnia; the trial is…
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients [Phase 3]
A Phase 3 trial of Circadin 2 mg evaluated its efficacy and safety in adults with primary insomnia. Results have been posted.
-
CLINICAL_TRIALS research · 2011-03-17Clinical Trial Update: Initial Study of Insomnia/Nightmare Group Treatment for Posttraumatic Stress Disorder (PTSD) [NA]
A report on an initial study of a group treatment for insomnia and nightmares in patients with posttraumatic stress disorder. The current st…
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
A pilot sleep-laboratory study comparing nocturnal bladder physiology in subjects with overactive bladder, insomnia, and healthy controls.
-
EMA guidance · 2011-02-26European Medicines Agency releases updated guidance on insomnia treatments
EMA has issued updated guidance on the development and use of treatments for insomnia, outlining recommendations for clinical evaluation and…
-
CLINICAL_TRIALS trial_result · 2011-02-04Clinical Trial Update: A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers [Phase 1]
A Phase 1 pharmacokinetic study to characterize absorption, metabolism, and excretion of [14C] PD 0200390 in six healthy male volunteers; th…
-
CLINICAL_TRIALS trial_result · 2010-12-28Clinical Trial Update: Suan Tsao Jen Tang for Treating Menopause With Sleep Problem: a Clinical Observation
Completed clinical observation study evaluating Suanzaoren Tang for menopause-related sleep problems.
-
FDA approval · 2010-12-17FDA Approved: EDLUAR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental NDA for EDLUAR (zolpidem tartrate) filed by Viatris Specialty LLC. The approval reflects changes approved as…
-
CLINICAL_TRIALS trial_result · 2010-12-14Clinical Trial Update: Actigraphic Analysis of Treatment Response [NA]
This clinical trial update reports completion and posting of results for actigraphic analysis of treatment response in sleep-related conditi…
-
FDA approval · 2010-12-08FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for zolpidem tartrate submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2010-11-30FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for zolpidem tartrate submitted by Sandoz Inc., resulting in changes to the labeling of this gen…
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year [Phase 3]
Phase 3 trial assessing efficacy and safety of eplivanserin for sleep maintenance insomnia, with an optional extension up to one year, has c…
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties [Phase 3]
A Phase 3 trial comparing eplivanserin with lormetazepam for insomnia characterized by sleep maintenance difficulties has completed accordin…
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia [Phase 3]
This document provides an update on a Phase 3 trial evaluating the efficacy and safety of Eplivanserin 5 mg daily for sleep maintenance inso…
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia [Phase 1]
Phase 1 study in children with insomnia evaluating the safety, tolerability, and pharmacokinetic/pharmacodynamic profile of a single dose of…
-
FDA approval · 2010-11-22FDA Approved: IBUPROFEN, DIPHENHYDRAMINE HCL — Original Application (Bionpharma Inc.)
FDA approved the original application for a combination product of ibuprofen and diphenhydramine HCl by Bionpharma Inc., intended for tempor…